Testosterone Undeconate (Nebido-R, BAY86-5037)

Pre-clinicalCompleted
0 watching 0 views this week๐Ÿ’ค Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism

Trial Timeline

Jun 1, 2007 โ†’ Oct 1, 2008

About Testosterone Undeconate (Nebido-R, BAY86-5037)

Testosterone Undeconate (Nebido-R, BAY86-5037) is a pre-clinical stage product being developed by Bayer for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT00847314. Target conditions include Hypogonadism.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT00847314Pre-clinicalCompleted
NCT00838838Pre-clinicalCompleted